Detail Information of Transcriptional Regulations

General Information of Drug Transporter (DT)
DT ID DTD0452 Transporter Info
Gene Name SLC6A2
Transporter Name Sodium-dependent noradrenaline transporter
Gene ID
6530
UniProt ID
P23975

Transcriptional Regulation of This DT (TSR)

TF Superclass 2: Zinc-coordinating DNA-binding domains

      Class 2.1: Nuclear receptors with C4 zinc fingers

Click to Show/Hide the Full List of 1 TF(s) Regulating This DT

        NR3C1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A2 gene in brain neuroblastoma condition [1]

TF Protein Name

 Glucocorticoid receptor Transcription Factor Info

Studied Phenotype

 Brain neuroblastoma [ICD11: 2A00.11]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 human neuroblastoma cells (SK-N-BE(2)-M17)

Detailed Description

 Glucocorticoid receptor (NR3C1) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter.

      Class 2.3: C2H2 zinc finger factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        SCRT1 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC6A2 gene in attention deficit hyperactivity disorder condition [2]

TF Protein Name

 Transcriptional repressor scratch 1 Transcription Factor Info

Studied Phenotype

 Attention deficit hyperactivity disorder [ICD11: 6A05]

Tissue

 Brain

Related DT Changes

 Down regulating

Experimental Material

 Human attention-deficit hyperactivity disorder cell isolates

Detailed Description

 Transcriptional repressor scratch 1 (SCRT1) has been reported to repress the transcription of SLC6A2 gene in attention deficit hyperactivity disorder condition, which leads to a decreased expression of the drug transporter Sodium-dependent noradrenaline transporter.

        SNAI2 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Repression of SLC6A2 gene in attention deficit hyperactivity disorder condition [2]

TF Protein Name

 Zinc finger protein SNAI2 Transcription Factor Info

Studied Phenotype

 Attention deficit hyperactivity disorder [ICD11: 6A05]

Tissue

 Brain

Related DT Changes

 Down regulating

Experimental Material

 Human attention-deficit hyperactivity disorder cell isolates

Detailed Description

 Zinc finger protein SNAI2 (SNAI2) has been reported to repress the transcription of SLC6A2 gene in attention deficit hyperactivity disorder condition, which leads to a decreased expression of the drug transporter Sodium-dependent noradrenaline transporter.

TF Superclass 3: Helix-turn-helix domains

      Class 3.1: Homeo domain factors

Click to Show/Hide the Full List of 2 TF(s) Regulating This DT

        HOXA5 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A2 gene in brain neuroblastoma condition [3]

TF Protein Name

 Homeobox protein Hox-A5 Transcription Factor Info

Studied Phenotype

 Brain neuroblastoma [ICD11: 2A00.11]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 human neuroblastoma cells (SK-N-BE(2)-C)

Detailed Description

 Homeobox protein Hox-A5 (HOXA5) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter.

        PHOX2A 

Click to Show/Hide to Show 1 Transcriptional Phenomena      

       Transcriptional Phenomenon 1

 Activation of SLC6A2 gene in brain neuroblastoma condition [3]

TF Protein Name

 Paired mesoderm homeobox protein 2A Transcription Factor Info

Studied Phenotype

 Brain neuroblastoma [ICD11: 2A00.11]

Tissue

 Brain

Related DT Changes

 Up regulating

Experimental Material

 human neuroblastoma cells (SK-N-BE(2)-C)

Detailed Description

 Paired mesoderm homeobox protein 2A (PHOX2A) has been reported to activate the transcription of SLC6A2 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Sodium-dependent noradrenaline transporter.
References
1 Dexamethasone-induced up-regulation of the human norepinephrine transporter involves the glucocorticoid receptor and increased binding of C/EBP-beta to the proximal promoter of norepinephrine transporter. J Neurochem. 2011 Nov;119(3):654-63.
2 A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19164-9.
3 A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene. J Neurosci. 2002 Apr 1;22(7):2579-89.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.